DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹16,747 Cr | ₹13,034 Cr | ₹9,588 Cr | ₹8,572 Cr | ₹9,766 Cr |
What is the latest Total Current Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹16,747 Cr |
| Mar2025 | ₹13,034 Cr |
| Mar2024 | ₹9,588 Cr |
| Mar2023 | ₹8,572 Cr |
| Mar2022 | ₹9,766 Cr |
How is Total Current Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹16,747 Cr | 28.49 | |
| Mar2025 | ₹13,034 Cr | 35.94 | |
| Mar2024 | ₹9,588 Cr | 11.85 | |
| Mar2023 | ₹8,572 Cr | -12.22 | |
| Mar2022 | ₹9,766 Cr | - | |
Compare Total Current Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹115,856.1 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
| MANKIND PHARMA | ₹107,613.0 Cr | -1.4% | 11.5% | 19.5% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.4% |
13.1% |
13.7% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses